Cell culture models | [References] |
Electronic cigarette vapour exposure | |
Air-liquid interface | [11, 12, 16, 17, 19, 21, 28, 34, 54, 55, 65, 66, 71, 73, 74, 77, 78, 103] |
E-liquid mixed with cell medium or electronic cigarette vapour extracts | [13–15, 18, 20, 22, 47, 50–53, 56–58, 70, 72, 75, 76, 79, 81, 104] |
Cell types | |
Lung epithelial cells | |
16HBE (human) | [16, 53f, 64] |
hTBE (human) | [52] |
A549 cells (human) | [12, 13, 18, 50, 58, 64, 73] |
NHBE (human) | [17, 20, 28, 65, 73] |
Beas-2B (human) | [11, 13, 19, 47, 55, 58, 76] |
H292 (human) | [19, 47, 74] |
Primary bronchial epithelial cells (human) | [16, 21, 55] |
Primary small airway epithelial cells (human) | [54] |
3-dimensional epithelial cell model (human) | [34, 78] |
Primary tracheal epithelial cells (mouse) | [53] |
RLEC (rat) | [76] |
Nasal epithelial cells | |
HBEpC | [58] |
3-dimensional epithelial cell model from healthy donors (human) | [77] |
Immune cells | |
White blood cells (human) | [18] |
Blood neutrophils (human) | [22, 56, 82] |
Blood monocyte-derived dendritic cells (human) | [104] |
THP-1 monocytic cells (human) | [15] |
Kupffer cells (rat) | [72] |
Platelets | [81] |
Endothelial cells | |
HUVEC (human) | [51, 70] |
Primary human microvascular cells-lung derived | [76] |
MLEC (mouse) | [76] |
Stem cells | |
Embryonic stem cells (human) | [14] |
Bone marrow-derived mesenchymal stem cells (human) | [75] |
Neural stem cells (mouse) | [14] |
Lung fibroblasts | |
Human pulmonary fibroblasts | [14] |
HFL-1 (human) | [19, 47, 103] |
Skin cells | |
HaCaTs (human) | [12, 18] |
Primary gingival epithelial cells (human) | [71, 80] |
Periodontal ligament fibroblasts (human) | [80] |
Lung surfactant | |
Infasurf (calf) | [79] |
Bacteria | |
Streptococcus pneumoniae | [57] |
Streptococcus gordonii | [66] |
Streptococcus intermedius | [66] |
Streptococcus mitis | [66] |
Streptococcus oralis | [66] |
Nicotine | |
Low nicotine <6 mg·mL−1 | [14, 19, 55, 57, 70, 76] |
Medium nicotine 6–18 mg·mL−1 | [11, 14, 15, 19, 21, 47, 52, 75, 77, 81, 103–105] |
High nicotine >18 mg·mL−1 | [13, 14, 17, 19, 20, 22, 28, 47, 50, 54, 58, 66, 71–74, 78–80, 82, 104, 106] |
No nicotine | [13, 14, 16, 17, 19–21, 28, 47, 53, 54, 56–58, 66, 72, 73, 79–82] |
Unspecified concentration | [12] |
Flavours | |
Tobacco flavours | [11, 14, 19, 52, 54, 58, 70–74, 76–78, 80–82, 103, 105] |
Menthol | [11, 14, 74, 78–80] |
Cinnamon | [55] |
Coffee | [47] |
Fruit flavours | [14, 15, 19, 50, 53, 57, 74, 75, 79] |
Dessert and sweet drink flavours | [14, 19, 53, 74, 76] |
Other | [12] |
Targeted aromatic molecules | [19, 47, 51, 53, 56] |
Unflavoured | [11, 13, 14, 16, 19–22, 28, 55, 66, 76, 79, 104, 106] |
HBE: human bronchial epithelial; NHBE: normal and diseased bronchial epithelial.